Cargando…

Gene delivery to pancreatic exocrine cells in vivo and in vitro

BACKGROUND: Effective gene transfer to the pancreas or to pancreatic cells has remained elusive although it is essential for studies of genetic lineage tracing and modulation of gene expression. Different transduction methods and viral vectors were tested in vitro and in vivo, in rat and mouse pancr...

Descripción completa

Detalles Bibliográficos
Autores principales: Houbracken, Isabelle, Baeyens, Luc, Ravassard, Philippe, Heimberg, Harry, Bouwens, Luc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3487942/
https://www.ncbi.nlm.nih.gov/pubmed/23088534
http://dx.doi.org/10.1186/1472-6750-12-74
_version_ 1782248549641093120
author Houbracken, Isabelle
Baeyens, Luc
Ravassard, Philippe
Heimberg, Harry
Bouwens, Luc
author_facet Houbracken, Isabelle
Baeyens, Luc
Ravassard, Philippe
Heimberg, Harry
Bouwens, Luc
author_sort Houbracken, Isabelle
collection PubMed
description BACKGROUND: Effective gene transfer to the pancreas or to pancreatic cells has remained elusive although it is essential for studies of genetic lineage tracing and modulation of gene expression. Different transduction methods and viral vectors were tested in vitro and in vivo, in rat and mouse pancreas. RESULTS: For in vitro transfection/transduction of rat exocrine cells lipofection reagents, adenoviral vectors, and Mokola- and VSV-G pseudotyped lentiviral vectors were used. For in vivo transduction of mouse and rat pancreas adenoviral vectors and VSV-G lentiviral vectors were injected into the parenchymal tissue. Both lipofection of rat exocrine cell cultures and transduction with Mokola pseudotyped lentiviral vectors were inefficient and resulted in less than 4% EGFP expressing cells. Adenoviral transduction was highly efficient but its usefulness for gene delivery to rat exocrine cells in vitro was hampered by a drastic increase in cell death. In vitro transduction of rat exocrine cells was most optimal with VSV-G pseudotyped lentiviral vectors, with stable transgene expression, no significant effect on cell survival and about 40% transduced cells. In vivo, pancreatic cells could not be transduced by intra-parenchymal administration of lentiviral vectors in mouse and rat pancreas. However, a high efficiency could be obtained by adenoviral vectors, resulting in transient transduction of mainly exocrine acinar cells. Injection in immune-deficient animals diminished leukocyte infiltration and prolonged transgene expression. CONCLUSIONS: In summary, our study remarkably demonstrates that transduction of pancreatic exocrine cells requires lentiviral vectors in vitro but adenoviral vectors in vivo.
format Online
Article
Text
id pubmed-3487942
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-34879422012-11-03 Gene delivery to pancreatic exocrine cells in vivo and in vitro Houbracken, Isabelle Baeyens, Luc Ravassard, Philippe Heimberg, Harry Bouwens, Luc BMC Biotechnol Research Article BACKGROUND: Effective gene transfer to the pancreas or to pancreatic cells has remained elusive although it is essential for studies of genetic lineage tracing and modulation of gene expression. Different transduction methods and viral vectors were tested in vitro and in vivo, in rat and mouse pancreas. RESULTS: For in vitro transfection/transduction of rat exocrine cells lipofection reagents, adenoviral vectors, and Mokola- and VSV-G pseudotyped lentiviral vectors were used. For in vivo transduction of mouse and rat pancreas adenoviral vectors and VSV-G lentiviral vectors were injected into the parenchymal tissue. Both lipofection of rat exocrine cell cultures and transduction with Mokola pseudotyped lentiviral vectors were inefficient and resulted in less than 4% EGFP expressing cells. Adenoviral transduction was highly efficient but its usefulness for gene delivery to rat exocrine cells in vitro was hampered by a drastic increase in cell death. In vitro transduction of rat exocrine cells was most optimal with VSV-G pseudotyped lentiviral vectors, with stable transgene expression, no significant effect on cell survival and about 40% transduced cells. In vivo, pancreatic cells could not be transduced by intra-parenchymal administration of lentiviral vectors in mouse and rat pancreas. However, a high efficiency could be obtained by adenoviral vectors, resulting in transient transduction of mainly exocrine acinar cells. Injection in immune-deficient animals diminished leukocyte infiltration and prolonged transgene expression. CONCLUSIONS: In summary, our study remarkably demonstrates that transduction of pancreatic exocrine cells requires lentiviral vectors in vitro but adenoviral vectors in vivo. BioMed Central 2012-10-22 /pmc/articles/PMC3487942/ /pubmed/23088534 http://dx.doi.org/10.1186/1472-6750-12-74 Text en Copyright ©2012 Houbracken et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Houbracken, Isabelle
Baeyens, Luc
Ravassard, Philippe
Heimberg, Harry
Bouwens, Luc
Gene delivery to pancreatic exocrine cells in vivo and in vitro
title Gene delivery to pancreatic exocrine cells in vivo and in vitro
title_full Gene delivery to pancreatic exocrine cells in vivo and in vitro
title_fullStr Gene delivery to pancreatic exocrine cells in vivo and in vitro
title_full_unstemmed Gene delivery to pancreatic exocrine cells in vivo and in vitro
title_short Gene delivery to pancreatic exocrine cells in vivo and in vitro
title_sort gene delivery to pancreatic exocrine cells in vivo and in vitro
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3487942/
https://www.ncbi.nlm.nih.gov/pubmed/23088534
http://dx.doi.org/10.1186/1472-6750-12-74
work_keys_str_mv AT houbrackenisabelle genedeliverytopancreaticexocrinecellsinvivoandinvitro
AT baeyensluc genedeliverytopancreaticexocrinecellsinvivoandinvitro
AT ravassardphilippe genedeliverytopancreaticexocrinecellsinvivoandinvitro
AT heimbergharry genedeliverytopancreaticexocrinecellsinvivoandinvitro
AT bouwensluc genedeliverytopancreaticexocrinecellsinvivoandinvitro